PERSPECTA

News from every angle

← Back to headlines

SciSparc Stock Surges on NeuroThera's CliniQuantum Deal Approval

SciSparc's stock more than doubled after NeuroThera received conditional approval for its CliniQuantum deal, signaling a significant market reaction.

28 May, 16:53 — 28 May, 16:53
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed95d ago

SciSparc more than doubles as NeuroThera wins conditional nod for CliniQuantum deal

Read full article →

Related Stories

South Korea Reports Record Export Surge in August Driven by Chip Demand

34m ago

Anthropic Secures $35 Billion Cloud Computing Deal With Nvidia-Backed Lambda

50m ago

Nigeria Reports 4.43 Percent Economic Growth in Second Quarter

57m ago

Hyundai Motor South Korean Union Approves New Wage Deal

1h ago